These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15152956)

  • 1. Vaginal estrogen preparations for relief of atrophic vaginitis.
    Nothnagle M; Taylor JS
    Am Fam Physician; 2004 May; 69(9):2111-2. PubMed ID: 15152956
    [No Abstract]   [Full Text] [Related]  

  • 2. By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Nov; 15(3):7. PubMed ID: 18225330
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postmenopausal atrophic colpitis--its local treatment with low-dose estradiol].
    Rachev E
    Akush Ginekol (Sofiia); 1995; 34(1):41-2. PubMed ID: 7485806
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why the product labeling for low-dose vaginal estrogen should be changed.
    Manson JE; Goldstein SR; Kagan R; Kaunitz AM; Liu JH; Pinkerton JV; Rebar RW; Schnatz PF; Shifren JL; Stuenkel CA; Gass ML; Utian WH;
    Menopause; 2014 Sep; 21(9):911-6. PubMed ID: 25140698
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
    Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
    Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic vaginitis.
    Stika CS
    Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvovaginal complaints.
    Mehta A; Bachmann G
    Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case for prophylactic vaginal estrogen?
    Morris E; Currie H
    Menopause Int; 2010 Dec; 16(4):135. PubMed ID: 21156848
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of atrophic vaginitis.
    Bachmann GA; Nevadunsky NS
    Am Fam Physician; 2000 May; 61(10):3090-6. PubMed ID: 10839558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
    Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
    Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
    Rozenberg S; Pastijn A; Gevers R; Murillo D
    Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
    Cicinelli E
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulvovaginal atrophy: new and upcoming approaches.
    Simon JA
    Menopause; 2009; 16(1):5-7. PubMed ID: 19131842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.